The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double‐blind and placebo‐controlled trial

ConclusionThese findings suggest the probable efficacy of pioglitazone as an augmentation therapy in reducing the negative symptoms of schizophrenia. Copyright © 2016 John Wiley & Sons, Ltd.

Source: Human Psychopharmacology: Clinical and Experimental - February 8, 2016 Category: Psychiatry Authors: Negar Iranpour, Atefeh Zandifar, Mehdi Farokhnia, Amirhossein Goguol, Habibeh Yekehtaz, Mohammad‐Reza Khodaie‐Ardakani, Bahman Salehi, Sophia Esalatmanesh, Atefeh Zeionoddini, Payam Mohammadinejad, Arefeh Zeinoddini, Shahin Akhondzadeh Tags: Research Article Source Type: research